- Hodgkin Lymphoma
- Multiple Myeloma
- Chronic Lymphocytic Leukemia
- Meet The Professor Sessions
- Chronic Myeloid Leukemia
- Myeloproliferative Neoplasms
- Breakfast With The Expert
- Independent Satellite Symposium
- Plenary Sessions
- Evolving Practices in AML: A Case-based Guide to New and Emerging Treatment Options
- Acute Lymphoblastic Leukemia
- Myelodysplastic Syndromes
- Acute Myeloid Leukemia
- Indolent B-cell Lymphoma
- Mantle Cell Lymphoma
- Aggressive B-cell Lymphoma
- T-cell Lymphoma
- Cellular Therapy
- Next Questions
- Events
Playback speed
10 seconds
AL Amyloidosis Therapy and Targets in 2019: Bortezomib Remains Mainstay in Frontline, ASCT in Upfront Is Questionable, Targeted Therapies Offer Promise, IO to Be Proven
88 views
November 18, 2019
Login to view comments.
Click here to Login
Multiple Myeloma